CR10375A - Acidos bifenilcarboxilicos sustituidos y sus derivados - Google Patents

Acidos bifenilcarboxilicos sustituidos y sus derivados

Info

Publication number
CR10375A
CR10375A CR10375A CR10375A CR10375A CR 10375 A CR10375 A CR 10375A CR 10375 A CR10375 A CR 10375A CR 10375 A CR10375 A CR 10375A CR 10375 A CR10375 A CR 10375A
Authority
CR
Costa Rica
Prior art keywords
substituted
bifenyl
derivatives
carboxyl acids
compounds
Prior art date
Application number
CR10375A
Other languages
English (en)
Inventor
Wilson Francis
Reid Alison
Reader Valerie
John Harrison Richard
Sunose Mihiro
Hernadez-Perni Remedios
Major Jeremy
Boussard Cyrille
Smelt Kathryn
Taylor Jess
Leformal Adeline
Cansfield Andrew
Burckhardt Svenja
Yung Ho Chih
Zhang Yan
Original Assignee
Cellzome Ltd
Ortho Mcneil Janssen Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellzome Ltd, Ortho Mcneil Janssen Pharm filed Critical Cellzome Ltd
Publication of CR10375A publication Critical patent/CR10375A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invencion se relaciona con compuestos que tienen la Formula general (I) con las definiciones de X, Y, R1, R2, R3, R4, R9 y R10 y/o una sal o ester de dichos compuestos. Mas aun, la invencion se relaciona con el uso de dichos compuestos para el tratamiento de la enfermedad de Alzheimer y con su uso para la modulaicon de la actividad y-secretasa, en donde A es O, NH, S; X es un enlace o un grupo -CR5R6, Y es un grupo carboxi -C(O)OH o un grupo tetrazol sustituido o no sustituido.
CR10375A 2006-04-21 2008-10-17 Acidos bifenilcarboxilicos sustituidos y sus derivados CR10375A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112938A EP1849762B1 (en) 2006-04-21 2006-04-21 Substituted biphenyl carboxylic acids and derivatives thereof

Publications (1)

Publication Number Publication Date
CR10375A true CR10375A (es) 2009-02-26

Family

ID=36688012

Family Applications (2)

Application Number Title Priority Date Filing Date
CR10375A CR10375A (es) 2006-04-21 2008-10-17 Acidos bifenilcarboxilicos sustituidos y sus derivados
CR10451A CR10451A (es) 2006-04-21 2008-11-21 Acidos bifenilocarbocilicos substituidos y sus derivados

Family Applications After (1)

Application Number Title Priority Date Filing Date
CR10451A CR10451A (es) 2006-04-21 2008-11-21 Acidos bifenilocarbocilicos substituidos y sus derivados

Country Status (35)

Country Link
US (1) US7557244B2 (es)
EP (2) EP1849762B1 (es)
JP (1) JP5479088B2 (es)
KR (1) KR101542255B1 (es)
CN (1) CN101687758B (es)
AP (1) AP2008004656A0 (es)
AR (1) AR060568A1 (es)
AU (1) AU2007240335B2 (es)
BR (1) BRPI0710656A2 (es)
CA (1) CA2650006C (es)
CR (2) CR10375A (es)
CY (1) CY1109399T1 (es)
DE (1) DE602006007810D1 (es)
DK (1) DK1849762T3 (es)
EA (1) EA016129B9 (es)
ES (2) ES2328616T3 (es)
GE (1) GEP20115269B (es)
GT (1) GT200900120A (es)
IL (2) IL194852A0 (es)
MA (1) MA30475B1 (es)
MX (1) MX2008013445A (es)
MY (1) MY148953A (es)
NO (1) NO20084517L (es)
NZ (1) NZ573000A (es)
PE (1) PE20080364A1 (es)
PL (1) PL1849762T3 (es)
PT (1) PT1849762E (es)
SI (1) SI1849762T1 (es)
SM (1) SMP200800061B (es)
TN (1) TNSN08413A1 (es)
TW (1) TWI399362B (es)
UA (1) UA95952C2 (es)
UY (1) UY30301A1 (es)
WO (1) WO2007124394A1 (es)
ZA (1) ZA200809856B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008312371B2 (en) * 2007-10-19 2013-06-20 Janssen Pharmaceutica, N.V. Amine linked modulators of gamma-secretase
JP5439381B2 (ja) 2007-10-19 2014-03-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ γ−セクレターゼのピペリジニル及びピペラジニル調節物質
AU2008312362A1 (en) * 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. Gsm intermediates
WO2009052334A1 (en) 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
US20110092554A1 (en) * 2007-11-19 2011-04-21 Richard Chesworth 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
AU2008345573B2 (en) 2007-12-20 2013-12-19 Envivo Pharmaceuticals, Inc. Tetrasubstituted benzenes
EP2488031A4 (en) * 2009-10-16 2014-07-23 Merck Sharp & Dohme DIARYL ETHER DERIVATIVES AS A NOTCH-PROOFING GAMMETRETASE INHIBITOR
US8785481B2 (en) 2010-09-29 2014-07-22 Merck Sharp & Dohme Corp. Ether benzotriazole derivatives
WO2012119035A1 (en) * 2011-03-03 2012-09-07 Treventis Corporation Anti-amyloid compounds and methods
WO2015109109A1 (en) 2014-01-15 2015-07-23 Forum Pharmaceuticals Inc. Fused morpholinopyrimidines and methods of use thereof
US9802927B2 (en) 2015-06-10 2017-10-31 Denali Therapeutics, Inc. Oxadiazine compounds and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877399A (en) 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
JP3802581B2 (ja) * 1995-03-01 2006-07-26 富山化学工業株式会社 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤
AU5702201A (en) 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
DE10131899A1 (de) 2001-07-04 2003-02-27 Boehringer Ingelheim Pharma In vitro-Screening-Assay für gamma-Secretase
EP1546086A2 (en) * 2002-06-27 2005-06-29 Fujisawa Pharmaceutical Co., Ltd. Aminoalcohol derivatives
GB0305918D0 (en) * 2003-03-14 2003-04-23 Glaxo Group Ltd Novel compounds
WO2005110963A1 (en) * 2004-05-19 2005-11-24 Cellzome Ag (biphenyl-3-yl)-carboxylic acids and derivatives thereof and their use in therapy
GB0416508D0 (en) * 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
WO2006022237A1 (ja) * 2004-08-24 2006-03-02 Kissei Pharmaceutical Co., Ltd. 脂肪肝の予防または治療剤
US8148572B2 (en) * 2005-10-06 2012-04-03 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
CA2650006C (en) 2016-08-23
AU2007240335B2 (en) 2013-05-02
DE602006007810D1 (de) 2009-08-27
GT200900120A (es) 2009-11-16
WO2007124394A1 (en) 2007-11-01
NO20084517L (no) 2009-01-13
MA30475B1 (fr) 2009-06-01
SMAP200800061A (it) 2008-11-19
CN101687758B (zh) 2014-05-14
KR101542255B1 (ko) 2015-08-06
EA200802172A1 (ru) 2009-06-30
TW200815320A (en) 2008-04-01
JP2009544573A (ja) 2009-12-17
CN101687758A (zh) 2010-03-31
MX2008013445A (es) 2009-03-10
MY148953A (en) 2013-06-14
EA016129B1 (ru) 2012-02-28
BRPI0710656A2 (pt) 2011-08-16
DK1849762T3 (da) 2009-10-12
TWI399362B (zh) 2013-06-21
SMP200800061B (it) 2009-07-14
CA2650006A1 (en) 2007-11-01
AP2008004656A0 (en) 2008-10-31
KR20090024679A (ko) 2009-03-09
PT1849762E (pt) 2009-09-16
CR10451A (es) 2009-03-31
AU2007240335A1 (en) 2007-11-01
US7557244B2 (en) 2009-07-07
EP1849762A1 (en) 2007-10-31
EP2021314A1 (en) 2009-02-11
UA95952C2 (ru) 2011-09-26
ZA200809856B (en) 2009-06-24
IL194790A0 (en) 2009-08-03
IL194790A (en) 2012-12-31
ES2328616T3 (es) 2009-11-16
EP1849762B1 (en) 2009-07-15
EP2021314B1 (en) 2013-01-23
TNSN08413A1 (en) 2010-04-14
US20070293567A1 (en) 2007-12-20
ES2400530T3 (es) 2013-04-10
UY30301A1 (es) 2007-08-31
IL194852A0 (en) 2009-08-03
PL1849762T3 (pl) 2009-12-31
AR060568A1 (es) 2008-06-25
NZ573000A (en) 2011-11-25
EA016129B9 (ru) 2012-06-29
CY1109399T1 (el) 2014-07-02
GEP20115269B (en) 2011-08-25
SI1849762T1 (sl) 2009-12-31
PE20080364A1 (es) 2008-05-16
JP5479088B2 (ja) 2014-04-23

Similar Documents

Publication Publication Date Title
CR10375A (es) Acidos bifenilcarboxilicos sustituidos y sus derivados
NI200700107A (es) (bifenil) ácidos carboxílicos y sus derivados
CR10452A (es) Derivados de terfenilo para el tratamiento de enfermedad de alzheimer
PE20090211A1 (es) Inhibidores de las iap
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
ATE554085T1 (de) Neue inhibitoren von glutaminylcyclase
DOP2002000392A (es) Sales tartrato de 5,8,14 triazatetraciclo [10.3.1.024 0.4.9] hexadeca-2 (11), 3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
CU23848B1 (es) Derivados de octahidrofenantreno n(2-metilpiridino-3-il) carboxamida útiles como moduladores de receptor de glucocorticoides
UY30408A1 (es) Derivados sustituidos del acetato de 8-(4-metoxifenil)-2,3,4,8-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones
CY1110969T1 (el) 5-υποκατεστημενα-2-φαινυλαμινο-βενζαμιδια ως αναστολεiς μεκ
BRPI0617167B8 (pt) sulfonilpirróis como inibidores de hdac&#39;s, seu uso, composição farmacêutica e combinação
UY31084A1 (es) Compuestos de azaindol para la inhibicion de b-secretasa
AR071538A1 (es) Derivados de macrolactona
NI201000058A (es) Ácidos bifenil carboxílicos y derivados de los mismos.
ATE432262T1 (de) Pyrazolphenylderivate als ppar-aktivatoren
AR077429A1 (es) Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos
AR046212A1 (es) Derivados de 2-fenilbenzofurano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
CR9070A (es) Acidos (bifenil) carboxilicos y derivados de estos
UA94574C2 (ru) (бифенил) карбоновые кислоты и их производные
CY1112068T1 (el) (διφαινυλ) καρβοξυλικα οξεα και τα παραγωγα αυτων
DE502005000652D1 (de) Neue Arzneimittel
TH80960A (th) ซัลฟานิลแทนที่ฟีนิลเมทธาโนนซ์
HN2008000426A (es) Compuestos de pirimidina amida como inhibidores de pgds

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)